Prices re-read October 15, 2026Methodology v4.1How we score →
Compare Providers
Home / Corrections policy

Released: ·Last reviewed: ·Methodology v4.1

Researched By
Medical Researcher · Western University of Health Sciences
Last medically reviewed: August 4, 2026 · This page is informational and does not constitute medical advice.
This page is maintained. Prices are re-read at source and dated; evidence is checked against the published trial. Newest across the site: news · research · corrections.

Corrections policy

How to report an error, how we respond, and how corrections are labeled and logged.

Reporting an error

Email corrections@transparrentpeptide.com with the page URL, the claim in question, and supporting evidence. Providers and readers can both submit corrections.

How we handle corrections

We correct objective factual errors and log the change with a date. Providers may correct facts with evidence; they cannot negotiate scores, suppress accurate criticism, or require positive language.

Correction levels

Minor (formatting), factual (corrected with a dated note and updated modified date), and material methodology/data changes (score updated, version incremented). Material corrections are submitted through IndexNow so search and AI systems re-crawl promptly.

How the dates on this page work. Manufacturer self-pay prices were re-read on 15 October 2026: NovoCare’s Wegovy page and Lilly’s Zepbound savings page. Foundayo prices are carried from LillyDirect pages archived 25 September 2026, because lilly.com blocked automated reads. Figures captured from telehealth provider websites carry the date we read that provider’s page, which may be earlier; where it is, the row or a dated notice says so. We do not restamp a figure we have not re-read.